Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical, Inc. (COLL) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $25.55, up 0.45% on the day, which values the company at $793.82M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$25.55+0.45% today
Market value
$793.82M
P/E ratio
23.4×last 12 months
Forward P/E
3.6×
Funk Score
75/100
Against its own history
Well below its usual priceusual price $43.51
200-week average
$31.5719% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Collegium Pharmaceutical, Inc. in more detail

COLL trades at 23.4× its last twelve months' earnings, 3.6× next year's expected earnings, 1.0× sales. Measured against its own history, the price is 41% below what its usual multiples would imply ($43.51) — well below its usual price. It sits 19% below its 200-week average of $31.57.

Over the last five fiscal years Collegium Pharmaceutical, Inc. has compounded revenue 20.3% a year, earnings per share 17.9% a year, free cash flow 30.0% a year. Its Funk Score is 75 out of 100 (financial strength 3.9, profitability 7.8, growth 9.2, value 9.0, each out of 10).

In its favour: Strong Piotroski score; High return on invested capital. Worth checking: Altman Z in the distress zone.

1 of the superinvestors tracked here hold COLL, including Third Avenue team (0.8% of the portfolio).

Superinvestors holding COLL

1 of the investors tracked here report a position in their latest 13F filing.

Collegium Pharmaceutical, Inc. (COLL): questions and answers

What is COLL's P/E ratio?

Collegium Pharmaceutical, Inc. trades at 23.4× its last twelve months' earnings and 3.6× next year's expected earnings. At its fiscal year-ends over the past 5 years the P/E ranged from 10.0× to 26.8×, with a median of 23.9×.

What is COLL's PEG ratio?

Collegium Pharmaceutical, Inc.'s PEG ratio is 0.74 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Collegium Pharmaceutical, Inc.'s market cap?

Collegium Pharmaceutical, Inc. is valued at $793.82M at a share price of $25.55.

Is COLL overvalued or undervalued?

Against its own history, COLL is well below its usual price: the price is 41% below the $43.51 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is COLL above its 200-week moving average?

No. COLL is 19.1% below its 200-week average of $31.57. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Collegium Pharmaceutical, Inc. growing?

Over the last five fiscal years Collegium Pharmaceutical, Inc.'s revenue grew 20.3% a year and its earnings per share 17.9% a year.

Cite this page

Funkfolio, “Collegium Pharmaceutical, Inc. (COLL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COLL

Underlying data: Yahoo Finance; company filings with the SEC.